Joe Garland, MD
What the Patients Ordered
A dedicated HIV doctor opens up about the job he loves and how he faced one of the most difficult decisions…
Do One Thing
With new, game-changing hepatitis C meds available or in the pipeline, an emerging issue is how to find at-risk patients, get them screened and…
Vpu Inhibitor Candidate
BIT225 is a new type of antiviral called a Vpu inhibitor, which researchers are investigating to treat both HIV and HIV/hepatitis C (HCV) co-infection….
Man Up Mondays
An independent interim review of the Strategic Timing of AntiRetroviral Treatment (START) study findings shows that initializing treatment early improves outcomes for individuals with…
What’s the Matter with Indiana?
At a news briefing on April 24, the Centers for Disease Control and Prevention said that urgent action was needed to control the outbreak…
HIV in the South
Southern Exposure
The Southern U.S. is Now the Region Hardest Hit by HIV/AIDS—What’s Really Going on Down South and What Needs to be Done to…
MSF Access Campaign
Without Borders
A global campaign for providing low-cost HCV care rolls out
by Larry Buhl
Last year UNITAID funded two grants to increase access to new treatments…
Countdown to a Cure
by Jeannie Wraight
As part of the Countdown to a Cure Initiative, amfAR (The Foundation for AIDS Research) will direct $20 million, of a $100…
Silk-Protein Film
LifeGuide
Blocking the First Step
A silk-protein film aims to become an HIV prevention method
by Chael Needle
When we think of HIV prevention in sexually active…
Condoms & Corrections
Condoms & Corrections
California’s controversial new law will provide safer-sex tools to prisoners
by Larry Buhl
In 1987 Vermont was the first state to supply condoms to…